Fred Alger Management
CLVS

Fred Alger Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Fred Alger Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35,447
Closed -$139K – 538
2019
Q3 		$139K Hold
35,447
– – ﹤0.01% 405
2019
Q2 		$527K Sell
35,447
-54,964
-61% -$993K ﹤0.01% 376
2019
Q1 		$2.24M Buy
90,411
+12,115
+15% +$304K 0.01% 278
2018
Q4 		$1.41M Buy
78,296
+7,218
+10% +$147K 0.01% 297
2018
Q3 		$2.09M Sell
71,078
-101,278
-59% -$3.92M 0.01% 283
2018
Q2 		$7.84M Buy
172,356
+51,054
+42% +$2.48M 0.03% 191
2018
Q1 		$6.41M Sell
121,302
-521,407
-81% -$30.4M 0.03% 205
2017
Q4 		$43.7M Sell
642,709
-185,698
-22% -$13M 0.2% 97
2017
Q3 		$68.3M Buy
828,407
+270,727
+49% +$21.5M 0.32% 75
2017
Q2 		$52.2M Buy
557,680
+390,645
+234% +$23.9M 0.25% 85
2017
Q1 		$10.6M Buy
167,035
+97,527
+140% +$5.93M 0.05% 169
2016
Q4 		$3.09M Buy
69,508
+50,508
+266% +$1.78M 0.02% 225
2016
Q3 		$685K Buy
+19,000
New +$408K ﹤0.01% 337
2015
Q4 		– Sell
-104,991
Closed -$9.65M – 602
2015
Q3 		$9.65M Sell
104,991
-31,033
-23% -$2.69M 0.05% 190
2015
Q2 		$12M Sell
136,024
-18,095
-12% -$1.55M 0.05% 208
2015
Q1 		$11.4M Buy
154,119
+153,514
+25,374% +$10.8M 0.05% 246
2014
Q4 		$34K Hold
605
– – ﹤0.01% 496
2014
Q3 		$27K Hold
605
– – ﹤0.01% 510
2014
Q2 		$25K Hold
605
– – ﹤0.01% 524
2014
Q1 		$42K Buy
605
+15
+3% +$1.1K ﹤0.01% 484
2013
Q4 		$36K Hold
590
– – ﹤0.01% 469
2013
Q3 		$36K Buy
+590
New +$41.8K ﹤0.01% 474

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Fred Alger Management's CLVS Position: Q4 2019 in Review

Fred Alger Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 35,447 shares — an estimated $139K sold.

Fred Alger Management first reported a position in CLVS in Q3 2013 and held it in 22 quarters. The position peaked at $68.3M in Q3 2017. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • Fred Alger Management reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • Fred Alger Management sold 35,447 Clovis Oncology, Inc. shares in Q4 2019, an estimated $139K.
  • Fred Alger Management first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 22 quarters.
  • Fred Alger Management's Clovis Oncology, Inc. position peaked at $68.3M in Q3 2017.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Fred Alger Management's 13F filing for Q4 2019, filed 14 Feb 2020.